Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Dec 10;20(1):1217.
doi: 10.1186/s12885-020-07713-4.

Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction

Affiliations
Comparative Study

Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction

Danielle E Desa et al. BMC Cancer. .

Abstract

Background: Metastases are the leading cause of breast cancer-related deaths. The tumor microenvironment impacts cancer progression and metastatic ability. Fibrillar collagen, a major extracellular matrix component, can be studied using the light scattering phenomenon known as second-harmonic generation (SHG). The ratio of forward- to backward-scattered SHG photons (F/B) is sensitive to collagen fiber internal structure and has been shown to be an independent prognostic indicator of metastasis-free survival time (MFS). Here we assess the effects of heterogeneity in the tumor matrix on the possible use of F/B as a prognostic tool.

Methods: SHG imaging was performed on sectioned primary tumor excisions from 95 untreated, estrogen receptor-positive, lymph node negative invasive ductal carcinoma patients. We identified two distinct regions whose collagen displayed different average F/B values, indicative of spatial heterogeneity: the cellular tumor bulk and surrounding tumor-stroma interface. To evaluate the impact of heterogeneity on F/B's prognostic ability, we performed SHG imaging in the tumor bulk and tumor-stroma interface, calculated a 21-gene recurrence score (surrogate for OncotypeDX®, or S-ODX) for each patient and evaluated their combined prognostic ability.

Results: We found that F/B measured in tumor-stroma interface, but not tumor bulk, is prognostic of MFS using three methods to select pixels for analysis: an intensity threshold selected by a blinded observer, a histogram-based thresholding method, and an adaptive thresholding method. Using both regression trees and Random Survival Forests for MFS outcome, we obtained data-driven prediction rules that show F/B from tumor-stroma interface, but not tumor bulk, and S-ODX both contribute to predicting MFS in this patient cohort. We also separated patients into low-intermediate (S-ODX < 26) and high risk (S-ODX ≥26) groups. In the low-intermediate risk group, comprised of patients not typically recommended for adjuvant chemotherapy, we find that F/B from the tumor-stroma interface is prognostic of MFS and can identify a patient cohort with poor outcomes.

Conclusions: These data demonstrate that intratumoral heterogeneity in F/B values can play an important role in its possible use as a prognostic marker, and that F/B from tumor-stroma interface of primary tumor excisions may provide useful information to stratify patients by metastatic risk.

Keywords: Breast cancer; Collagen; F/B; Metastasis; Multiphoton microscopy; Prognosis; Second-harmonic generation; Tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

RLH and EBB are inventors on patent #US10,765,376 related to the methods in this paper. All other authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Collagen F/B is heterogeneous within primary breast tumor tissue. SHG F/B images (a series of adjacent ROIs extending along the x-axis) and matching H&E images were stitched end-to-end to form a composite ROI for a representative sample. Examples of tumor bulk (solid box), tumor-stroma interface (dashed box), and uninvolved tissue (circle) are shown. The F/B values were plotted in a false color “heatmap” (low F/B values = dark blue, high F/B values = yellow) to illustrate differences in F/B within the tumor region including tumor bulk and tumor-stroma interface, indicating intratumoral heterogeneity in F/B
Fig. 2
Fig. 2
Collagen features vary between the tumor bulk and the tumor-stroma interface of primary tumor excisions. Primary tumor excisions contain both tumor bulk (solid boxes) and tumor-stroma interface (dashed boxes). Tumor bulk consists of tumor cell clusters surrounded by individual SHG-producing fiber bundles. The tumor-stroma interface is comprised mainly of closely packed collagen fibers and individual stromal cells adjacent to the tumor bulk. Representative SHG F/B and matching H&E images from 3 individual patients are shown. The scale bar applies to all images in this figure
Fig. 3
Fig. 3
F/B in tumor-stroma interface versus tumor bulk. Collagen fiber internal structure, as represented by F/B, is significantly different between tumor bulk and the tumor-stroma interface in IDC ER+ LNN excised primary tumors. Error bars = SD, t-test, p < 0.0001, n = 92
Fig. 4
Fig. 4
F/B measured in tumor-stroma interface and bulk of primary tumor sections and relation to MFS. SHG F/B values were produced by a user-defined threshold for each individual image from the a, tumor bulk and b, tumor-stroma interface. Patients were split into four equal quartiles (Q1 = lowest F/B) based on F/B, and the percentage of each quartile surviving without metastasis then plotted versus time. Tick marks represent censoring events caused when a patient dies of a cause other than cancer or is lost to follow-up. Partial likelihood ratio tests for ln F/B: p = 0.05 (tumor bulk, n = 95) and p = 0.00008 (tumor-stroma interface, n = 92)
Fig. 5
Fig. 5
F/B generated using histogram-based thresholding and its relation to MFS. SHG F/B values were produced using binary masks generated by a histogram-based thresholding method for each individual image taken in the a, tumor bulk and b, tumor-stroma interface. Patients were split into four equal quartiles (Q1 = lowest F/B) based on F/B, and the percentage of each quartile surviving without metastasis then plotted versus time. Tick marks represent censoring events caused when a patient dies of a cause other than cancer or is lost to follow-up. Partial likelihood ratio tests for ln F/B: p = 0.01 (tumor bulk, n = 95) and p = 0.0009 (tumor-stroma interface, n = 92)
Fig. 6
Fig. 6
F/B generated using adaptive thresholding and its relation to MFS. An adaptive thresholding method was used to create binary masks used to calculate SHG F/B in the a, tumor bulk and b, tumor-stroma interface. Patients were split into four equal quartiles (Q1 = lowest F/B) based on F/B, and the percentage of each quartile surviving without metastasis then plotted versus time. Tick marks represent censoring events caused when a patient dies of a cause other than cancer or is lost to follow-up. Partial likelihood ratio test p = 0.4 (tumor bulk, n = 95) and p = 0.002 (tumor-stroma interface, n = 92)
Fig. 7
Fig. 7
Regression tree derived using the method of Leblanc & Crowley. When given the SODX score and all six methods of generating F/B as inputs, this algorithm selects F/B from the tumor-stroma interface, calculated using the adaptive thresholding method (“FB_THI_AT”), and SODX score (“SODX_score”), as predictors of MFS. The RSF method (results not shown) identifies the same two predictors has having the highest variable importance in predicting MFS
Fig. 8
Fig. 8
F/B is prognostic of MFS in the tumor-stroma interface of primary excisions with S-ODX < 26. Patients were divided by S-ODX score and then each group was split into four equal quartiles (Q1 = lowest F/B) based on F/B. The three higher quartiles (Q2-Q4) were pooled, and the percentage of each quartile surviving without metastasis then plotted versus time for these two groups (Q1 and Q2-Q4). a, S-ODX < 26 and b, S-ODX ≥26. Tick marks represent censoring events caused when a patient dies of a cause other than cancer or is lost to follow-up. Partial likelihood ratio test a p = 0.008, n = 62, b p = 0.4, n = 30

References

    1. Cancer Stat Facts SEER. Female breast Cancer. Bethesda. MD: National Cancer Institute. Available from: https://seer.cancer.gov/statfacts/html/breast.html.
    1. Clark BZ, Onisko A, Assylbekova B, Li X, Bhargava R, Dabbs DJ. Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity. Mod Pathol. 2019;32(3):354–366. doi: 10.1038/s41379-018-0153-0. - DOI - PubMed
    1. Turashvili G, Brogi E. Tumor Heterogeneity in Breast Cancer. Front Med (Lausanne) 2017;4:227. doi: 10.3389/fmed.2017.00227. - DOI - PMC - PubMed
    1. Patani N, Barbashina V, Lambros MB, Gauthier A, Mansour M, Mackay A, et al. Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype. J Clin Pathol. 2011;64(9):822–828. doi: 10.1136/jclinpath-2011-200135. - DOI - PubMed
    1. Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol. 2010;220(5):562–573. doi: 10.1002/path.2675. - DOI - PubMed

Publication types

MeSH terms